
'TagrisSO I Can Live Longer': AstraZeneca Targets Lung Cancer Patients
Around 30,000 people annually in the U.S. with non-small cell lung cancer (NSCLC) also get diagnosed with specific epidermal growth factor receptor (EGFR) gene mutations, a condition that affects mostly non-smokers. It’s a $4 billion+ market globally, says …